UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000049208
Receipt No. R000056046
Scientific Title Association of weight loss during neoadjuvant therapy with failure to rescue and in-hospital mortality after esophagectomy for esophageal cancer
Date of disclosure of the study information 2022/10/13
Last modified on 2022/10/13 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Association of weight loss during neoadjuvant therapy with failure to rescue and in-hospital mortality after esophagectomy for esophageal cancer
Acronym Association of weight loss during neoadjuvant therapy with failure to rescue and in-hospital mortality after esophagectomy for esophageal cancer
Scientific Title Association of weight loss during neoadjuvant therapy with failure to rescue and in-hospital mortality after esophagectomy for esophageal cancer
Scientific Title:Acronym Association of weight loss during neoadjuvant therapy with failure to rescue and in-hospital mortality after esophagectomy for esophageal cancer
Region
Japan

Condition
Condition Esophageal cancer
Classification by specialty
Gastrointestinal surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 This retrospective study assessed the effect of weight loss during neoadjuvant therapy on failure to rescue after esophagectomy.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes in-hospital mortality, failure to rescue
Key secondary outcomes major complications, respiratory complications, anastomotic leakage, length of stay after surgery, total hospitalization costs

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients who underwent esophagectomy after neoadjuvant therapy between July 2010 and March 2019 were identified from a Japanese nationwide inpatient database.
Key exclusion criteria The exclusion criteria were as follows:patients who underwent combined surgery for laryngeal or hypopharyngeal cancer; and patients who were outliers for height (<100 or >200 cm), weight (<20 or >200 kg), body mass index (BMI) (<12.5 or >60 kg/m2), or weight change during neoadjuvant therapy (>30% gain or >30% loss). We also excluded patients who underwent neoadjuvant therapy and esophagectomy during the same hospitalization.
Target sample size 15000

Research contact person
Name of lead principal investigator
1st name Yuki
Middle name
Last name Hirano
Organization International University of Health and Welfare School of Medicine
Division name Department of Hepatobiliary-Pancreatic and Gastrointestinal Surgery
Zip code 2868520
Address 852 Hatakeda, Narita, Chiba, Japan
TEL 0476355600
Email yukihirano@iuhw.ac.jp

Public contact
Name of contact person
1st name Yuki
Middle name
Last name Hirano
Organization International University of Health and Welfare School of Medicine
Division name Department of Hepatobiliary-Pancreatic and Gastrointestinal Surgery
Zip code 2868520
Address 852 Hatakeda, Narita, Chiba, Japan
TEL 0476355600
Homepage URL
Email yukihirano@iuhw.ac.jp

Sponsor
Institute The University of Tokyo
Institute
Department

Funding Source
Organization The Ministry of Health, Labour and Welfare
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization The University of Tokyo
Address 7-3-1 Hongo, Bunkyo-ku, Tokyo
Tel 03-5841-0818
Email ethics@m.u-tokyo.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 10 Month 13 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 15159
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2022 Year 04 Month 01 Day
Date of IRB
2022 Year 05 Month 01 Day
Anticipated trial start date
2022 Year 06 Month 01 Day
Last follow-up date
2022 Year 06 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information This retrospective cohort study was conducted using the Diagnosis Procedure Combination database, a Japanese nationwide inpatient database More than 8 million hospital administrative claims data and discharge abstracts from more than 1200 hospitals are collected annually in this database. All university hospitals are required to participate in the database, while other hospitals participate on a voluntary basis.

Management information
Registered date
2022 Year 10 Month 13 Day
Last modified on
2022 Year 10 Month 13 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056046